Garden Biology (300401.SZ) signed a new drug R&D project cooperation agreement with the Guangzhou National Laboratory.

Zhitong Finance APP News, Garden Biology (300401.SZ) announced that recently, the company signed a "25-Hydroxycholesterol New Drug R&D Project Cooperation Agreement" with the Guangzhou National Laboratory. Both parties agreed to cooperate in advancing the R&D, registration, production, and commercialization of 25-hydroxycholesterol and its prodrug broad-spectrum antiviral drugs through the establishment of a joint venture company. This drug candidate has significant market potential in the broad-spectrum antiviral field. The joint venture company will be led by the company for subsequent operations, with the company holding no less than 51% of the shares.